See up to 3 months of ECOR. The 7-day demo opens the 1M and 3M ranges and puts ECOR on your watchlist.
Start 7-day demoLatest ECOR insider trades
Thomas J. Errico - DirectorOpen-market purchase$49K
Michael Fox - OfficerOpen-market purchase$49K
About electroCore, Inc. (ECOR)
electroCore, Inc. files with the SEC under CIK 0001560258 and is classified as electromedical and electrotherapeutic apparatus. It is grouped with Health Care companies on this site.
ECOR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 15,000 | $147K |
| Open-market sale | 3 | 20,000 | $200K |
| Grant or award | 9 | 186,187 | |
ECOR insider transactions (Form 4)
4436 Form 4 filings on record, the earliest from May 23, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas J. Errico - Director | Open-market purchase | Common Stock | 5,000 | $9.82 footnote F2 | $49K | |
| ||||||
| Michael Fox - Officer | Open-market purchase | Common Stock | 5,000 | $9.80 | $49K | |
| Michael Fox - Officer | Grant or award | Common Stock | 5,000 | $9.80 | $49K | |
 James Charles Theofilos - Director | Grant or award | Common Stock | 11,123 footnote F1 | $0.00 | - | |
| ||||||
| Patricia Wilber - Director | Grant or award | Common Stock | 11,123 footnote F1 | $0.00 | - | |
| ||||||
 Elena Bonfiglioli - Director | Grant or award | Common Stock | 11,123 footnote F1 | $0.00 | - | |
| ||||||
| Michael Fox - Officer | Grant or award | Common Stock | 55,000 footnote F1 | $0.00 | - | |
| ||||||
 Julie Ann Goldstein - Director | Grant or award | Common Stock | 11,123 footnote F1 | $0.00 | - | |
| ||||||
| Thomas J. Errico - Director | Grant or award | Common Stock | 15,572 footnote F1 | $0.00 | - | |
| ||||||
 John P. Gandolfo - Director | Grant or award | Common Stock | 11,123 footnote F1 | $0.00 | - | |
| ||||||
 Joshua S. Lev - Officer | Grant or award | Common Stock | 55,000 footnote F1 | $0.00 | - | |
| ||||||
| Joshua S. Lev - Officer | Option exercise | Common Stock | 12,000 | $4.50 | $54K | |
| Joshua S. Lev - Officer | Open-market sale | Common Stock | 12,000 | $10.22 footnote F2 | $123K | |
| Joshua S. Lev - Officer | Option exercise | Common Stock | 5,000 | $4.50 | $23K | |
| Joshua S. Lev - Officer | Open-market sale | Common Stock | 5,000 | $9.88 footnote F3 | $49K | |
| Joshua S. Lev - Officer | Option exercise | Common Stock | 3,000 | $4.50 | $14K | |
| Joshua S. Lev - Officer | Open-market sale | Common Stock | 3,000 | $9.36 footnote F4 | $28K | |
| Joshua S. Lev - Officer | Option exercise | Stock Option (Right to Buy Common Stock) | 12,000 | $0.00 | - | |
| Joshua S. Lev - Officer | Option exercise | Stock Option (Right to Buy Common Stock) | 5,000 | $0.00 | - | |
| Joshua S. Lev - Officer | Option exercise | Stock Option (Right to Buy Common Stock) | 3,000 | $0.00 | - | |
| ||||||
| Thomas J. Errico - Director | Open-market purchase | Common Stock | 5,000 | $9.85 footnote F1 | $49K | |
| ||||||
| Daniel S. Goldberger | Open-market sale | Common Stock | 80,000 | $6.80 footnote F1 | $544K | |
| ||||||
| Joshua S. Lev - Officer | Open-market sale | Common Stock | 6,667 | $9.00 footnote F1 | $60K | |
| ||||||
| Thomas J. Errico - Director | Other | Common Stock | 8 | $5.98 | $48 | |
| Thomas J. Errico - Director | Open-market purchase | Common Stock | 9,992 | $5.99 | $60K | |
| Joshua S. Lev - Officer | Open-market sale | Common Stock | 3,000 | $6.50 | $20K | |
| Michael Fox - Officer | Grant or award | Common Stock | 70,000 footnote F1 | $0.00 | - | |
| ||||||
| Daniel S. Goldberger | Open-market sale | Common Stock | 16,072 | $6.02 | $97K | |
| Joshua S. Lev - Officer | Grant or award | Common Stock | 45,000 footnote F1 | $0.00 | - | |
| ||||||
| Thomas J. Errico - Director | Other | Common Stock | 22,803 | $4.35 | $99K | |
| Thomas J. Errico - Director | Other | Warrants to Purchase Common Stock | 22,803 | $0.00 | - | |
| Thomas J. Errico - Director | Other | Warrants to Purchase Common Stock | 19,252 | $0.00 | - | |
| Thomas J. Errico - Director | Other | Common Stock | 19,252 | $6.43 | $124K | |
| Joshua S. Lev - Officer | Grant or award | Common Stock | 2,889 | $0.00 | - | |
| Joshua S. Lev - Officer | Grant or award | Common Stock | 25,000 footnote F1 | $0.00 | - | |
| ||||||
| Daniel S. Goldberger - Officer | Grant or award | Common Stock | 20,375 | $7.47 | $152K | |
| Daniel S. Goldberger - Officer | Grant or award | Common Stock | 26,000 footnote F1 | $0.00 | - | |
| ||||||
| Joshua S. Lev - Officer | Open-market sale | Common Stock | 2,500 | $5.05 footnote F1 | $13K | |
| ||||||
| Daniel S. Goldberger - Officer | Open-market purchase | Common Stock | 1,000 | $4.84 footnote F1 | $5K | |
| ||||||
| Joshua S. Lev - Officer | Open-market sale | Common Stock | 2,166 | $6.18 footnote F1 | $13K | |
| ||||||
| Elena Bonfiglioli - Director | Grant or award | Common Stock | 30,549 | $0.00 | - | |
| Thomas J. Errico - Director | Grant or award | Common Stock | 26,615 | $0.00 | - | |
| Patricia Wilber - Director | Grant or award | Common Stock | 19,011 | $0.00 | - | |
| Julie Ann Goldstein - Director | Grant or award | Common Stock | 19,011 | $0.00 | - | |
Item 5.02, 5.03, 5.07, 7.01, 9.01
Item 2.02, 9.01
Item 2.02, 9.01
Item 2.02, 9.01
Recent ECOR Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
ECOR insider trading FAQ
What is the latest insider trade for ECOR?
electroCore, Inc. (ECOR) had 13 insider filings in the last 90 days, with the most recent on 2026-09-22. The full record for ECOR runs to 36 Form 4 filings, the earliest from 2025-05-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ECOR stock?
3 insider purchases of ECOR were filed in the last 90 days, totaling $147K.
How many insiders are selling ECOR stock?
3 insider sales of ECOR were filed in the last 90 days, totaling $200K.
Where can I see ECOR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ECOR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Thomas J. Errico view on EDGAR
- - Michael Fox view on EDGAR
- - Michael Fox view on EDGAR
- - James Charles Theofilos view on EDGAR
- - Patricia Wilber view on EDGAR
- - Elena Bonfiglioli view on EDGAR
- - Michael Fox view on EDGAR
- - Julie Ann Goldstein view on EDGAR
- - Thomas J. Errico view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ECOR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ECOR with a 7-day demo
- ECOR on your watchlist
- Every ECOR Form 4 filing on record
- Up to 3 months of ECOR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
